Quantcast
Channel: BioSpace.com News
Browsing all 219 articles
Browse latest View live

SteadyMed Launches IPO

SAN RAMON, Calif., March 9, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the launch of its initial public offering of 4,250,000 ordinary shares at an...

View Article



Cancer Biotech Cellectis Sets Terms For $129 Million IPO

Cellectis, which is developing cancer immunotherapies based on gene-edited CAR T-cells, announced terms for its US offering on Wednesday.The Paris, France-based company plans to raise $129 million by...

View Article

Zhejiang ChiMin Pharma Stages $47 Million IPO In Shanghai

Zhejiang ChiMin Pharma recently completed an IPO on the Shanghai Stock Exchange, raising $47.4 million. The company specializes in generic IV solution drugs. ChiMin has been designated a National...

View Article

SteadyMed Announces Closing of Initial Public Offering

SAN RAMON, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the closing of its initial public offering of 4,700,000 ordinary shares at a...

View Article

Applied DNA Sciences, Inc. Prices $11.46 Million Public Offering

STONY BROOK, NY--(Marketwired - March 27, 2015) - Applied DNA Sciences, Inc. (APDN)(APDNW) (Twitter: @APDN), a provider of DNA-based anti-counterfeiting technology, supply chain and product...

View Article


Image may be NSFW.
Clik here to view.

Bone Repair Biotech PolyPid Ltd. Yanks $20M IPO As Selloff Continues

March 27, 2015By Riley McDermid, BioSpace.com Breaking News Sr. Editor...

View Article

Cancer Gene Therapy Biotech Files for a $70M IPO

MultiVir Files Registration Statement for Proposed Initial Public OfferingHOUSTON, March 30, 2015 /PRNewswire/ --MultiVir Inc. ("MultiVir"), a clinical-stage gene therapy company developing a pipeline...

View Article

Image may be NSFW.
Clik here to view.

After Exiting RTP, CoLucid Pharma Files with for $86M IPO

March 31, 2015By Krystle Vermes, BioSpace.com Breaking News StaffSince abruptly...

View Article


Botox Biotech Anterios Files For A $58 Million IPO

Anterios, which is developing a topical formulation of botulinum toxin, filed on Tuesday with the SEC to raise up to $58 million in an initial public offering.Revance Therapeutics (RVNC), which is also...

View Article


Image may be NSFW.
Clik here to view.

aTyr Pharma $76 Million Series E Gets IPO Rumors Flying

April 1, 2015By Mark Terry, BioSpace.com Breaking...

View Article

Image may be NSFW.
Clik here to view.

IPOs Dropped 54 Percent in the First Quarter, As VC Investment Stays on the...

April 6, 2015By Riley McDermid...

View Article

KemPharm Sets Terms for $52 Million IPO

KemPharm, which is developing abuse-deterrent versions of widely-prescribed pain medications, announced terms for its IPO on Friday. The Coralville, IA-based company plans to raise $52 million by...

View Article

Image may be NSFW.
Clik here to view.

Aduro Biotech Launches $119 Million IPO with Hot Cancer Tech

April 15, 2015By Mark Terry and

View Article


Shanghai Haohai Biological To Stage $305 Million IPO In Hong Kong

Shanghai Haohai Biological Technology, a company that makes medical products from absorbable biomedical materials, announced plans to raise as much as $305 million in an IPO on the Hong Kong Stock...

View Article

Image may be NSFW.
Clik here to view.

As Market Froths, Blueprint Medicines Debuts $147 Million IPO for...

April 30, 2015By Riley McDermid

View Article


Blueprint Medicines Announces Closing of Initial Public Offering

CAMBRIDGE, Mass., May 5, 2015 /PRNewswire/ --Blueprint Medicines (NASDAQ: BPMC) today announced the closing of its initial public offering of 9,367,708 shares of common stock at a public offering price...

View Article

Adaptimmune Announces Pricing Of IPO

OXFORD, United Kingdom and PHILADELPHIA, May 6, 2015 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) today announced the pricing of its initial public offering of 11,250,000 American...

View Article


GW Pharmaceuticals plc Announces The Closing Of U.S. Public Offering Of...

LONDON, May 5, 2015 /PRNewswire/ -- GW Pharmaceuticals plc (Nasdaq: GWPH, AIM: GWP, "GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing novel...

View Article

Collegium Announces Pricing Of Its IPO

CANTON, Mass., May 7, 2015 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc., (Nasdaq:COLL) today announced the pricing of its initial public offering of 5,800,000 shares of its common stock at a...

View Article

aTyr Pharma Announces Pricing Of Initial Public Offering

SAN DIEGO, May 6, 2015 /PRNewswire/ --aTyr Pharma, Inc. ("aTyr"), today announced the pricing of its initial public offering of 5,360,000 shares of its common stock at an initial public offering price...

View Article
Browsing all 219 articles
Browse latest View live




Latest Images